Physician profile
Lee Roberson
NPI 1790750065
$826.54
in general payments reported to CMS, 2019-2025
14 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $148 · 2021: $212 · 2023: $19.27 · 2024: $156 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $273.66 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Abbott Laboratories | $126.38 | 2021 | |
| Abiomed | $87.77 | 2021-2025 | |
| Edwards Lifesciences Corporation | $72.67 | 2020-2021 | |
| Chiesi USA, INC. | $52.61 | 2019-2021 | |
| Solventum Corporation | $37.80 | 2024 | Prevena |
| Davol INC. | $35.58 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $27.48 | 2025 | Keytruda Qlex, Keytruda |
| Kci USA, INC. | $24.67 | 2019 | |
| Zimmer Biomet Holdings, INC. | $21.70 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.27 | 2023 | |
| Livanova USA, INC. | $18.31 | 2019 | |
| Lsi Solutions INC | $17.11 | 2020 | |
| Baxter Healthcare | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Roberson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.